| cheap jordan 11 Low 7/18(土) 00:51:37 No.20150718005137
"We have identified what we believe is the definitive root cause and are aggressively testing potential solutions that we expect will address the issue," said Peter Brandt, Noven's president and chief executive officer. "As previously indicated, however, until testing is completed and solutions are implemented, voluntary actions like today's two lot recall are possible, as we work to assure that patients and caregivers can use Daytrana with the convenience they expect from this novel ADHD treatment."
|
|